Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Deloitte
Chubb
Teva
Covington
Cantor Fitzgerald

Generated: September 16, 2019

DrugPatentWatch Database Preview

Litigation Details for Merck Sharp & Dohme Corp. v. Savior Lifetec Corp. (E.D.N.C. 2015)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Merck Sharp & Dohme Corp. v. Savior Lifetec Corp. (E.D.N.C. 2015)

Docket   Try a Free Trial Date Filed 2015-08-21
Court District Court, E.D. North Carolina Date Terminated 2018-02-01
Cause 35:271 Patent Infringement Assigned To Terrence William Boyle
Jury Demand None Referred To
Parties MERCK SHARP & DOHME CORP.; SAVIOR LIFETEC CORP.
Patents 5,952,323
Attorneys Cecil K. Musgrove; John W. Bateman; Michael Paul Dougherty; Timothy G. Barber; Tony Valentine Pezzano; W. Michael Dowling; Wes J. Camden; William Michael Dowling
Firms Haynes and Boone, LLP; Hogan Lovells LLP; King & Spalding LLP; Ward and Smith, P.A., Post
Link to Docket External link to docket
Small Molecule Drugs cited in Merck Sharp & Dohme Corp. v. Savior Lifetec Corp.
The small molecule drug covered by the patent cited in this case is   Try a Free Trial .

Details for Merck Sharp & Dohme Corp. v. Savior Lifetec Corp. (E.D.N.C. 2015)

Date Filed Document No. Description Snippet Link To Document
2017-01-19 Summary Judgment That Claims 2 And 4-6 Of U.S. Patent No. 5,952,323 Are Invalid For Obviousness. (Stouch, L.…2015 1 February 2018 5:15-cv-00415 830 Patent None District Court, E.D. North External link to document
2017-06-01 106 . 6,486,150('150) and No. 5,952,323 ('323). Defendant (Savior) has stipulated that its generic…alleging patent infringement; at this stage, the litigation concerns only plaintiff's U.S. Patent No. …claims in the '323 patent, but challenges the validity of the '323 patent. Savior challenges both…respect to all claims concerning plaintiffs' 150 patent. The parties are ORDERED to notify the Court within…proceedings with respect to its claims relating to U.S. Patent No. 6,486,150. The approprfate responses and replies External link to document
2015-08-21 2 U.S. Patent No. 5,952,323 (the “‘323 patent”) which is attached as Exhibit A. The ‘323 patent discloses…and Legal Bases for its Opinion that U.S. Patent No. 5,952,323 Is Invalid, Unenforceable, and/or Not Infringed…the ‘323 patent to the FDA in connection with its NDA No. 021337, identifying it as a patent “with respect…with respect to the ‘323 patent constituted an act of infringement of that patent. 17. … the expiration of the ‘323 patent will directly infringe the ‘323 patent under 35 U.S.C. §271(a), will External link to document
2017-01-06 67 Summary Judgment That Claims 2 And 4-6 Of U.S. Patent No. 5,952,323 Are Invalid For Obviousness filed by Savior…2015 1 February 2018 5:15-cv-00415 830 Patent None District Court, E.D. North External link to document
2017-01-06 68 Summary Judgment That Claims 2 And 4-6 Of U.S. Patent No. 5,952,323 Are Invalid For Obviousness. (Dowling, William…2015 1 February 2018 5:15-cv-00415 830 Patent None District Court, E.D. North External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
US Army
Queensland Health
Chinese Patent Office
Farmers Insurance
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.